Competitors
| Companies | Market Cap | G | R | O | W | T | H |
|---|---|---|---|---|---|---|---|
|
Eli Lilly and NYSE:LLY |
761,68 B | 23,56% | 6/6 | 34,75% | 17,76% | 46,85% | DOWN |
|
Johnson & Johnson NYSE:JNJ |
547,28 B | 5,26% | 5/5 | 7,04% | -23,79% | 13,92% | UP |
|
Merck NYSE:MRK |
274,03 B | 7,67% | 6/6 | -21,36% | -3,72% | 21,68% | UP |
|
Pfizer NYSE:PFE |
149,38 B | 7,82% | 4/6 | -5,31% | 23,77% | 6,63% | UP |
|
Bristol-Myers Squibb NYSE:BMY |
117,58 B | 1,77% | 5/6 | -0,30% | 0,97% | 11,13% | UP |
|
Vertex Pharmaceuticals NasdaqGS:VRTX |
107,66 B | 13,44% | 6/6 | 6,43% | 2,37% | 32,19% | DOWN |
|
Regeneron Pharmaceuticals NasdaqGS:REGN |
69,83 B | 9,26% | 5/6 | 5,41% | 12,92% | 28,49% | UP |
|
Zoetis NYSE:ZTS |
47,87 B | 9,80% | 6/6 | 7,18% | 49,25% | 27,38% | DOWN |
|
United Therapeutics NasdaqGS:UTHR |
25,00 B | 15,13% | 5/6 | 2,41% | -46,73% | 15,69% | UP |
|
Viatris NasdaqGS:VTRS |
17,44 B | -3,69% | 4/6 | 2,85% | -51,65% | 13,48% | UP |
|
Madrigal Pharmaceuticals NasdaqGS:MDGL |
11,90 B | 0,00% | 2/4 | 0,00% | 0,00% | 24,71% | UP |
|
Catalent NYSE:CTLT |
11,52 B | -5,82% | 2/6 | 27,69% | -22,42% | 0,03% | UP |
|
Cytokinetics NasdaqGS:CYTK |
7,40 B | -1,08% | 1/6 | 4,92% | -29,65% | 56,96% | UP |
|
Balchem NasdaqGS:BCPC |
5,55 B | 8,75% | 6/6 | 8,46% | 1,44% | 16,79% | UP |
|
Indivior Pharmaceuticals NasdaqGS:INDV |
4,20 B | 28,91% | 5/6 | 13,62% | -11,88% | 5,02% | UP |
|
TG Therapeutics NasdaqCM:TGTX |
4,96 B | 63,45% | 3/5 | 33,54% | 93,20% | 36,99% | UP |
|
Corcept Therapeutics NasdaqCM:CORT |
5,00 B | 10,36% | 5/6 | 118,76% | 12,59% | 28,76% | DOWN |
|
Ligand Pharmaceuticals NasdaqGM:LGND |
4,51 B | 7,83% | 5/6 | 3,60% | -65,80% | 12,68% | UP |
|
Nektar Therapeutics NasdaqCM:NKTR |
2,80 B | 65,15% | 4/6 | 74,02% | -493,67% | 80,51% | UP |
|
Supernus Pharmaceuticals NasdaqGM:SUPN |
2,80 B | 2,48% | 3/6 | 8,61% | -23,63% | 31,74% | UP |
